Abstract:Background: While irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal diseases in clinical practice, it has diverse pathogenesis. Because of its sudden and lingering intractable symptoms, it seriously affects patients work and life. Opioid receptors are G protein-coupled receptors distributed across the brain, spinal cord, skin, and gastrointestinal tract, and each of the subtypes has a unique role and specific distribution. They play a role in regulating gastrointestinal motility, secretion, and visceral sensations in the gastrointestinal tract. Therefore, this meta-analysis aims to evaluate the effects of opioid receptor modulators on improving the symptoms of IBS. Methods: Searching the key words (Irritable Bowel Syndromes or Syndrome, Irritable Bowel OR Syndromes, Irritable Bowel OR Colon, Irritable OR Irritable Colon OR Colitis, Mucous OR Colitides, Mucous OR Mucous Colitides OR Mucous Colitis) AND (opioid receptor modulators OR eluxadoline OR Viberzi OR asimadoline OR loperamide), a preliminary search on PubMed (English), EMBASE (English), Cochrane Library (English), China National Knowledge Infrastructure Database (CNKI, Chinese), WanFang (Chinese), VIP citation databases (Chinese) and SinoMed (Chinese) databases yielded 1023 papers published in English and Chinese from inception to July 1, 2019. Nine studies were included in the final meta-analysis. Because this is a systematic review and meta-analysis, ethical approval is not necessary. Results: The random-effects meta-analysis based on these 9 studies and their 4156 patients found that opioid receptor modulators have a statistically significant beneficial effect on IBS global symptoms (RR = 0.85, 95%CI = 0.79-0.92, P < .01) and bowel movement frequency (SMD = -1.26, 95%CI = -2.49--0.04, P < .05), and while there was an improvement trend in stool consistency and quality of life, these findings were not statistically significant. Conclusions: This is the first meta-analysis to examine the use of opioid receptor modulators in IBS, and few adverse events were reported in the available trials. Compared with the control group, eluxadolin has a better effect in improving IBS global symptoms and abdominal pain and has statistical significance and showed a low rate of constipation development in IBS patients in comparison with known effects of other opioid receptor modulators. However, current findings are based on a considerably limited evidence base with marked heterogeneity. Future studies should aim to identify subpopulations of patients with IBS and need to evaluate the long-term safety of these therapies.PROSPERO registration number: CRD42020141597.

Effects of opium tincture on gastrointestinal function and motility in healthy volunteers: A magnetic resonance imaging study

[Effect of Morphine Chloride on Contractility of Small Intestinal Muscle in Vitro or in Vivo and Its Mechanisms].

Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids

Opioids and the Gastrointestinal Tract: The Role of Peripherally Active μ-Opioid Receptor Antagonists in Modulating Intestinal Permeability

The effect of gut microbiome on tolerance to morphine mediated antinociception in mice

Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine Via Peripheral Opioid Receptors

μ-Opioid Receptor–Mediated Enteric Glial Activation Is Involved in Morphine-Induced Constipation

Gut Microbiota and DTI Microstructural Brain Alterations in Rodents Due to Morphine Self-Administration

Novel insights into mechanisms of inhibition of colonic motility by loperamide

Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

Design, Synthesis, and Biological Evaluation of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan Derivatives As Peripheral Selective Μ Opioid Receptor Agents.

Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use

The combination of L-menthol and caraway oil does not affect gastric function but increases hunger in healthy subjects

Antidiarrheal Effect of Alpinia Oxyphylla Miq. (zingiberaceae) in Experimental Mice and Its Possible Mechanism of Action.

Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model

Ameliorative effects of the mixed aqueous extract of Aurantii Fructus Immaturus and Magnoliae Officinalis Cortex on loperamide-induced STC mice

Effects of Chinese herbal medicine Xiangbin prescription on gastrointestinal motility

The efficacy of abdominal massage in managing opioid-induced constipation

Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli